PREPARATION AND REVIEW OF CHEMISTRY, MANUFACTURING AND CONTROL (CMC) SECTIONS OF CTD DOSSIER FOR MARKETING AUTHORIZATION

  • Dhruvi H. Patel Ramanbhai Patel College of Pharmacy, CHARUSAT Campus, Changa- 388 001, Gujarat, India.
  • Jitendra Kumar Badjatya Umedica Laboratories Pvt. Ltd., Vapi, Gujarat, India.
  • Amit A Patel Ramanbhai Patel College of Pharmacy, CHARUSAT Campus, Changa- 388 001, Gujarat, India.
DOI https://doi.org/10.22270/ijdra.v5i2.196

Abstract

The present article summarizes & simplify the marketing application requirements i.e. the critical aspects of
marketing application in different CTD using countries, Process to prepare and review the requirements for CMC
section (Chemistry manufacturing & Control) for filing an application in regulated market. Study shows the
compilation of dossier as per CTD format with minimum errors during filing. The focus is on the application filing &
Query part that may come after submission & during approval process. So one has to focus on the requirements of
dossiers with minimal queries & study the probable queries that may arise after filing an application to regulated
countries. Once approved, the applicant can market the safe, effective, stable & quality generic drug product with low
cost to the public. The complete marketing application is based as per CTD format gives understanding of critical
aspects of Marketing Application and better understanding of dossier filing.
 

Keywords: CTD, CMC, Module, ICH, Dossier, Active Pharmaceutical Ingredients (API), Certificate of Analysis (COA).

Downloads

Download data is not yet available.

Author Biographies

Dhruvi H. Patel, Ramanbhai Patel College of Pharmacy, CHARUSAT Campus, Changa- 388 001, Gujarat, India.

Ramanbhai Patel College of Pharmacy, CHARUSAT Campus, Changa- 388 001, Gujarat, India.

Jitendra Kumar Badjatya, Umedica Laboratories Pvt. Ltd., Vapi, Gujarat, India.

Umedica Laboratories Pvt. Ltd., Vapi, Gujarat, India.

Amit A Patel, Ramanbhai Patel College of Pharmacy, CHARUSAT Campus, Changa- 388 001, Gujarat, India.

Ramanbhai Patel College of Pharmacy, CHARUSAT Campus, Changa- 388 001, Gujarat, India.

References

1. Guidance for Industry M4Q CTD [Internet]. US
Department of Health & Human Services, ICH;
August 2001 [Cited 2017 April 14]. Available from:
https://www.fda.gov/OHRMS/DOCKETS/98fr/02d-
0525gdl00001.PDF
2. Robinett RS Robin. Merck & Co., Inc, Merck.
[Internet]. 75th AMWA Conference; 2015 Oct
1[Cited 2017 April 11]. Available from:
http://www.amwa.org/files/Events/AC2015/OS_Slide
s/OS11_CMC101.pdf
3. Chemistry manufacturing and control requirements,
[Internet]. MaRS; 2010 [Cited 2017 April 17].
Available from:
https://www.marsdd.com/wpcontent/
uploads/2012/09/CMC-Requirements. pdf
4. European medicine of Agency [Internet].
CPMP/ICH; 2003 July [Cited 2017 April 19].
Available from:
http://www.ema.europa.eu/docs/en_GB/document_lib
rary/Scientific_guideline/2009/09/WC500002725.pdf
5. George Wade EMEA [Internet]. The Common
Technical Documents-Quality (CTD-Q); 2008 Feb
[Cited 2017 April 23]. Available from:
http://www.ema.europa.eu/docs/en_GB/document_lib
rary/Presentation/2009/10/WC500004211.pdf
6. Mr. R.M. Gupta. [Internet]. Top 50 Deficiencies in
CTD Dossiers [Cited 2017 April 09]. Available
From:
http://www.perfectdossier.com/pdf/Top%2050%20D
eficiencies%20in%20CTD%20Dossiers.pdf
Statistics
1558 Views | 3841 Downloads
How to Cite
Patel, D. H., J. K. Badjatya, and A. A. Patel. “PREPARATION AND REVIEW OF CHEMISTRY, MANUFACTURING AND CONTROL (CMC) SECTIONS OF CTD DOSSIER FOR MARKETING AUTHORIZATION”. International Journal of Drug Regulatory Affairs, Vol. 5, no. 2, June 2017, pp. 1-12, doi:10.22270/ijdra.v5i2.196.
Issue
Vol 5 No 2 (2017): VOLUME 5, ISSUE 2, 2017
Section
Review

The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.

I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.

Download link for COPYRIGHT FORM